This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Cytodigm, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jieni Xu - Innovator in Pharmaceutical Composition
Introduction
Jieni Xu is a notable inventor based in Quincy, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of agents that interact with Siglec receptors.
Latest Patents
Jieni Xu holds 1 patent for his invention titled "Pharmaceutical composition of Siglec-binding agents." This invention provides a pharmaceutical composition comprising an agent that can bind Siglec receptors on the cell surface. Additionally, it outlines the method of preparing the said pharmaceutical composition and its various uses.
Career Highlights
Jieni Xu is currently employed at Cytodigm, Inc., where he continues to advance his research and development efforts in the pharmaceutical industry. His work focuses on innovative solutions that can enhance therapeutic outcomes.
Collaborations
Jieni has collaborated with talented individuals such as Bin Wu and Zimeng Wang, contributing to a dynamic research environment that fosters innovation.
Conclusion
Jieni Xu's work in pharmaceutical compositions showcases his commitment to advancing medical science through innovative inventions. His contributions are paving the way for new therapeutic possibilities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile